Prosecution Insights
Last updated: April 19, 2026

Confo Therapeutics N V

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17607334 CHIMERIC PROTEINS AND METHODS TO SCREEN FOR COMPOUNDS AND LIGANDS BINDING TO GPCRS REYNOLDS, FRED H 1658 Final Rejection Oct 28, 2021
17607333 Screening Methods and Assays for Use with Transmembrane Proteins, in Particular with GPCRs GAO, ASHLEY HARTMAN 1678 Final Rejection Oct 28, 2021

Managing Confo Therapeutics N V's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month